Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1984 May;47(5):481–484. doi: 10.1136/jnnp.47.5.481

Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.

A M Palmer, N R Sims, D M Bowen, D Neary, J Palo, J Wikstrom, A N Davison
PMCID: PMC1027823  PMID: 6204017

Abstract

Concentrations of 3-methoxy-4-hydroxyphenylglycol (MHPG), 5-hydroxy indoleacetic acid (5-HIAA) and homovanillic acid (HVA) were determined in lumbar cerebrospinal fluid (CSF) from control subjects and patients of both presenile and senile age with histologically verified Alzheimer's dementia. CSF HVA increased with age in control but not in Alzheimer patients. HVA and 5-HIAA in the CSF of presenile Alzheimer patients was lower than that of age matched control subjects.

Full text

PDF
481

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adolfsson R., Gottfries C. G., Roos B. E., Winblad B. Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry. 1979 Sep;135:216–223. doi: 10.1192/bjp.135.3.216. [DOI] [PubMed] [Google Scholar]
  2. Adèr J. P., Postema F., Korf J. Contribution of the locus coeruleus to the adrenergic innervation of the rat spinal cord: a biochemical study. J Neural Transm. 1979;44(3):159–173. doi: 10.1007/BF01253060. [DOI] [PubMed] [Google Scholar]
  3. Andersson H., Roos B. E. Acidic monoamine metabolites in cerebrospinal fluid of children with hydrocephalus. Acta Neurol Scand Suppl. 1965;13(Pt 1):149–151. doi: 10.1111/j.1600-0404.1965.tb01871.x. [DOI] [PubMed] [Google Scholar]
  4. Bareggi S. R., Franceschi M., Bonini L., Zecca L., Smirne S. Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications? Arch Neurol. 1982 Nov;39(11):709–712. doi: 10.1001/archneur.1982.00510230035010. [DOI] [PubMed] [Google Scholar]
  5. Benton J. S., Bowen D. M., Allen S. J., Haan E. A., Davison A. N., Neary D., Murphy R. P., Snowden J. S. Alzheimer's disease as a disorder of isodendritic core. Lancet. 1982 Feb 20;1(8269):456–456. doi: 10.1016/s0140-6736(82)91667-1. [DOI] [PubMed] [Google Scholar]
  6. Bondareff W., Mountjoy C. Q., Roth M. Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Lancet. 1981 Apr 4;1(8223):783–784. doi: 10.1016/s0140-6736(81)92657-x. [DOI] [PubMed] [Google Scholar]
  7. Bowen D. M., Allen S. J., Benton J. S., Goodhardt M. J., Haan E. A., Palmer A. M., Sims N. R., Smith C. C., Spillane J. A., Esiri M. M. Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J Neurochem. 1983 Jul;41(1):266–272. doi: 10.1111/j.1471-4159.1983.tb11838.x. [DOI] [PubMed] [Google Scholar]
  8. Bowen D. M., Sims N. R., Benton J. S., Curzon G., Davison A. N., Neary D., Thomas D. J. Treatment of Alzheimer's disease: a cautionary note. N Engl J Med. 1981 Oct 22;305(17):1016–1016. doi: 10.1056/NEJM198110223051714. [DOI] [PubMed] [Google Scholar]
  9. Bowers M. B., Jr, Gerbode F. A. Relationship of monoamine metabolites in human cerebrospinal fluid to age. Nature. 1968 Sep 21;219(5160):1256–1257. doi: 10.1038/2191256a0. [DOI] [PubMed] [Google Scholar]
  10. Coblentz J. M., Mattis S., Zingesser L. H., Kasoff S. S., Wiśniewski H. M., Katzman R. Presenile dementia. Clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol. 1973 Nov;29(5):299–308. doi: 10.1001/archneur.1973.00490290039003. [DOI] [PubMed] [Google Scholar]
  11. Commissiong J. W., Hellström S. O., Neff N. H. A new projection from locus coeruleus to the spinal ventral columns: histochemical and biochemical evidence. Brain Res. 1978 Jun 9;148(1):207–213. doi: 10.1016/0006-8993(78)90391-8. [DOI] [PubMed] [Google Scholar]
  12. Cross A. J., Crow T. J., Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J (Clin Res Ed) 1981 Jan 10;282(6258):93–94. doi: 10.1136/bmj.282.6258.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Curzon G., Gumpert E. J., Sharpe D. M. Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid. Nat New Biol. 1971 Jun 9;231(23):189–191. doi: 10.1038/newbio231189a0. [DOI] [PubMed] [Google Scholar]
  14. Garelis E., Sourkes T. L. Sites of origin in the central nervous system of monoamine metabolites measured in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1973 Aug;36(4):625–629. doi: 10.1136/jnnp.36.4.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gottfires C. G., Roos B. E. Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease). Acta Psychiatr Scand. 1973;49(3):257–263. doi: 10.1111/j.1600-0447.1973.tb04419.x. [DOI] [PubMed] [Google Scholar]
  16. Gottfries C. G., Gottfries I., Johansson B., Olsson R., Persson T., Roos B. E., Sjöström R. Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex. Neuropharmacology. 1971 Nov;10(6):665–672. doi: 10.1016/0028-3908(71)90081-5. [DOI] [PubMed] [Google Scholar]
  17. Gottfries C. G., Gottfries I., Roos B. E. Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid related to rated mental and motor impairment in senile and presenile dementia. Acta Psychiatr Scand. 1970;46(2):99–105. [PubMed] [Google Scholar]
  18. Gottfries C. G., Gottfries I., Roos B. E. Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism. J Neurochem. 1969 Sep;16(9):1341–1345. doi: 10.1111/j.1471-4159.1969.tb05984.x. [DOI] [PubMed] [Google Scholar]
  19. Gottfries C. G., Kjällquist A., Pontén U., Roos B. E., Sundbärg G. Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease. Br J Psychiatry. 1974 Mar;124(0):280–287. doi: 10.1192/bjp.124.3.280. [DOI] [PubMed] [Google Scholar]
  20. Mann D. M., Lincoln J., Yates P. O., Stamp J. E., Toper S. Changes in the monoamine containing neurones of the human CNS in senile dementia. Br J Psychiatry. 1980 Jun;136:533–541. doi: 10.1192/bjp.136.6.533. [DOI] [PubMed] [Google Scholar]
  21. Mann J. J., Stanley M., Neophytides A., de Leon M. J., Ferris S. H., Gershon S. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit. Neurobiol Aging. 1981 Spring;2(1):57–60. doi: 10.1016/0197-4580(81)90060-9. [DOI] [PubMed] [Google Scholar]
  22. Parkes J. D., Marsden C. D., Rees J. E., Curzon G., Kantamaneni B. D., Knill-Jones R., Akbar A., Das S., Kataria M. Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa. Q J Med. 1974 Jan;43(169):49–61. [PubMed] [Google Scholar]
  23. Perry E. K., Tomlinson B. E., Blessed G., Perry R. H., Cross A. J., Crow T. J. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. J Neurol Sci. 1981 Aug;51(2):279–287. doi: 10.1016/0022-510x(81)90106-4. [DOI] [PubMed] [Google Scholar]
  24. Post R. M., Goodwin F. K., Gordon E., Watkin D. M. Amine metabolites in human cerebrospinal fluid: effects of cord transection and spinal fluid block. Science. 1973 Mar 2;179(4076):897–899. doi: 10.1126/science.179.4076.897. [DOI] [PubMed] [Google Scholar]
  25. Sims N. R., Bowen D. M., Allen S. J., Smith C. C., Neary D., Thomas D. J., Davison A. N. Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem. 1983 Feb;40(2):503–509. doi: 10.1111/j.1471-4159.1983.tb11311.x. [DOI] [PubMed] [Google Scholar]
  26. Sjöström R., Ekstedt J., Anggård E. Concentration gradients of monoamine metabolites in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1975 Jul;38(7):666–668. doi: 10.1136/jnnp.38.7.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Soininen H., MacDonald E., Rekonen M., Riekkinen P. J. Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand. 1981 Aug;64(2):101–107. doi: 10.1111/j.1600-0404.1981.tb04392.x. [DOI] [PubMed] [Google Scholar]
  28. Tomlinson B. E. Plaques, tangles and Alzheimer's disease. Psychol Med. 1982 Aug;12(3):449–459. doi: 10.1017/s0033291700055549. [DOI] [PubMed] [Google Scholar]
  29. Wood P. L., Etienne P., Lal S., Gauthier S., Cajal S., Nair N. P. Reduced lumbar CSF somatostatin levels in Alzheimer's disease. Life Sci. 1982 Nov 8;31(19):2073–2079. doi: 10.1016/0024-3205(82)90099-6. [DOI] [PubMed] [Google Scholar]
  30. Yates C. M., Allison Y., Simpson J., Maloney A. F., Gordon A. Dopamine in Alzheimer's disease and senile dementia. Lancet. 1979 Oct 20;2(8147):851–852. doi: 10.1016/s0140-6736(79)92202-5. [DOI] [PubMed] [Google Scholar]
  31. Young S. N., Lal S., Martin J. B., Ford R. M., Sourkes T. L. 5-Hydroxyindoleacetic acid, homovanillic acid and tryptophan levels in CSF above and below a complete block of CSF flow. Psychiatr Neurol Neurochir. 1973 Nov-Dec;76(6):439–444. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES